The Valley Desk

ArticleCancer medicinePublished

CD4+ T Cells Mediate Dendritic Cell Licensing to Promote Multi-Antigen Anti-Leukemic Immune Response

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Article
Venue
Cancer medicine
Published
Subject terms
Dendritic Cells; CD4-Positive T-Lymphocytes; Cell Line, Tumor; Animals; Humans; Mice; Disease Models, Animal; Antigens, Neoplasm; Immunotherapy; Lymphocyte Activation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Dendritic cells
PubMed ID
39727041
PubMed Central ID
PMC11671796
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal